Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) - Total Liabilities
Based on the latest financial reports, Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) has total liabilities worth $6.20 Million USD as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CUPR cash flow metrics to assess how effectively this company generates cash.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares - Total Liabilities Trend (2021–2024)
This chart illustrates how Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. See net assets of Cuprina Holdings (Cayman) Limited Class for net asset value and shareholders' equity analysis.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Camellia Plc
LSE:CAM
|
UK | GBX128.80 Million |
|
OurLiving AB
ST:OURLIV
|
Sweden | Skr8.99 Million |
|
Mobeus Income And Growth Vct Plc
LSE:MIX
|
UK | GBX880.32K |
|
Appili Therapeutics Inc
TO:APLI
|
Canada | CA$16.93 Million |
|
Helios Underwriting PLC
LSE:HUW
|
UK | GBX69.89 Million |
|
Alpha Star Acquisition Corp
NASDAQ:ALSA
|
USA | $4.46 Million |
|
Fintech Chain Ltd
AU:FTC
|
Australia | AU$54.97 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CUPR stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (2021–2024)
The table below shows the annual total liabilities of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $6.20 Million | +38.41% |
| 2023-12-31 | $4.48 Million | +39.46% |
| 2022-12-31 | $3.21 Million | +96.41% |
| 2021-12-31 | $1.64 Million | -- |
About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collag… Read more